http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02209808-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
filingDate 1989-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e079b69045f394b5d5fb241c633be136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e0ae39a5848a0c9a6ef6dae2f8e966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e24e2d5fef79ee873ddb5ae63e2a513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52bdba2bbd9d5335fdf4938a0695b4a
publicationDate 1990-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02209808-A
titleOfInvention Therapy of drug addiction
abstract PURPOSE: To treat the abuse and addiction of addictive drugs by administration of an effective amount of an azapyrone compound or its acid-added salt. n CONSTITUTION: An effective amount of a compound of formula I [Z is a group of formula II to formula V (a real line with a dotted line denotes a single or double bond; A is O, CH 2 , CH 2 CH 2 or CH=CH; R 3 and R 4 are each H, a 1-4C alkyl, or joined together into butanediyl or pentanediyl); R 1 and R 2 are joined together into a group of formula VI, or such that R 1 is H and R 2 a group of formula VII] or a pharmaceutically effective acid added salt thereof, e.g. buspirone, gepirone, ipsapirone, is administered to treat overeating, food intake disorders, and drug addiction including addictive use of cigarettes, marihuana, cocaine, opium agents, methadone, amphetamines, methylphenidate and related designer drugs, and other recreational drugs. The daily therapeutically effective dose of the compound is 10-80 (pref. 30-60)mg. n COPYRIGHT: (C)1990,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6107330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706139-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526832-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015180673-A
priorityDate 1988-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4158
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416053110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458228

Total number of triples: 64.